{
    "nctId": "NCT02506530",
    "briefTitle": "Treatment Pathway of Patients Suffering From a Breast Cancer Related Lymphoedema",
    "officialTitle": "Contribution of an Endermologie LPG Cellu M6 Treatment in the Treatment Pathway of Patients Suffering From a Breast Cancer Related Lymphoedema, During an Intensive Decongestive Treatment.",
    "overallStatus": "COMPLETED",
    "conditions": "Lymphedema",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 93,
    "primaryOutcomeMeasure": "The proportion of patients successfully treated (reduction of the excessive volume in the arm>30%)",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients suffering from a lymphoedema consequence of a breast cancer of grades 2 or 3 (ISL)\n* Patients suffering from Lymphoedema for 6 months or more\n* Patients with a difference between arms \\>10%\n* Patients who had ever had an axillary node dissection\n* Patients hospitalized for intensive standard treatment.\n\nExclusion Criteria:\n\n* Primary lymphoedema\n* Venous insufficiency of the upper members\n* severe arterial obstruction\n* obliterating arteritis of the upper limbs\n* Bilateral lymphoedema\n* Breast cancer recurrence\n* Another cancer in treatment\n* Decompensated heart failure\n* Pacemaker\n* acute infection\n* Deep venous thrombosis\n* Skin atrophy of the upper member\n* Bullous dermatosis\n* Acute dermatitis with epidermitis or dermatitis-hypodermitis\n* Infected wound\n* Inflammatory scar or consequence of a recent surgery (\\<1 month)\n* Presence of osteosynthesis equipment under the skin with an external part in the upper member to treat\n* Hyperalgesia of the shoulder\n* Pregnancy.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}